NewBiotics Names President

Article

Pharmaceutical developer NewBiotics Inc. of San Diego, Calif., has named H. Michael Shepard, PhD, as company president.

Shepard was chief scientific officer and vice president of research at Canji, Inc. before taking the position. He helped develop the p53 gene product for cancer therapy and worked with management to secure financing for the company.

NewBiotics is privately held and is primarily researching breakthrough drugs to treat cancer and infectious disease.

Shepard was a Damon Runyon Fellow at Indiana University and received his doctorate in molecular, cellular, and developmental biology.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
"Top 5" in a blue ribbon  (Adobe Stock 235182652 by Evgeny)
Bug of the Month
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
© 2025 MJH Life Sciences

All rights reserved.